5-HT1A receptor imaging in the human brain: Effect of tryptophan depletion and infusion on [18F]MPPF binding

Synapse

Volumn 46, Issue 2, 2002, Pages 108-115

  Udo De Haes, Joanna I ^a   Bosker, Fokko J ^a   Van Waarde, Aren ^a   Pruim, Jan ^a   Willemsen, Antoon T M ^a   Vaalburg, Willem ^a   Den Boer, Johan A ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

5 HT1A receptor; 18F MPPF; Affinity; Extrasynaptic; Intrasynaptic; PET; Serotonin

Indexed keywords

4 (2' METHOXYPHENYL) 1 [2' (N 2'' PYRIDINYL) 4 FLUOROBENZAMIDO]ETHYLPIPERAZINE F 18; PIPERAZINE DERIVATIVE; SEROTONIN 1A RECEPTOR; TRYPTOPHAN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BINDING AFFINITY; BINDING KINETICS; BRAIN CORTEX; CONTROLLED STUDY; DRUG INFUSION; HUMAN; MALE; NORMAL HUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RAPHE NUCLEUS; TEMPORAL CORTEX; TRYPTOPHAN BRAIN LEVEL;

ADULT; AMINOPYRIDINES; HUMANS; MALE; MIDDLE AGED; PIPERAZINES; RADIOLIGAND ASSAY; RECEPTORS, SEROTONIN; RECEPTORS, SEROTONIN, 5-HT1; SEROTONIN ANTAGONISTS; TEMPORAL LOBE; TOMOGRAPHY, EMISSION-COMPUTED; TRYPTOPHAN;

EID: 0036837460     PISSN: 08874476     EISSN: None     Source Type: Journal    
DOI: 10.1002/syn.10134     Document Type: Article

References (48)

1. 1A receptor in primate brain neurons and glial cells. Neuropsychopharmacology 14:35-46.
2. 1A receptor in schizophrenia: a promising target for novel atypical neuroleptics? J Psychopharmacol 15:37-46.
3. Barnes NM, Sharp T. 1999. A review of central 5-HT receptors and their function. Neuropharmacology 38:1083-1152.
4. Blier P, de-Montigny C. 1994. Current advances and trends in the treatment of depression. Trends Pharmacol Sci 15:220-226.
5. Carpenter LL, Anderson GM, Pelton GH, Gudin JA, Kirwin PD, Price LH, Heninger GR, McDougle CJ. 1998. Tryptophan depletion during continuous CSF sampling in healthy human subjects. Neuropsychopharmacology 19:26-35.
6. Delgado PL, Charney DS, Price LH, Aghajanian GK, Landis H, Heninger GR. 1990. Serotonin function and the mechanism of antidepressant action. Reversal of antidepressant-induced remission by rapid depletion of plasma tryptophan. Arch Gen Psychiatry 47:411-418.
7. Drevets WC, Frank E, Price JC, Kupfer DJ, Holt D, Greer PJ, Huang Y, Gautier C, Mathis C. 1999. PET imaging of serotonin 1A receptor binding in depression. Biol Psychiatry 46:1375-1387.
8. Endres CJ, Carson RE. 1998. Assessment of dynamic neurotransmitter changes with bolus or infusion delivery of neuroreceptor ligands. J Cereb Blood Flow Metab 18:1196-1210.
9. Eynard N, Flachaire E, Lestra C, Broyer M, Zaidan R, Claustrat B, Quincy C. 1993. Platelet serotonin content and free and total plasma tryptophan in healthy volunteers during 24 hours. Clin Chem 39:2337-2340.
10. Fernstrom JD, Wurtman RJ. 1971. Brain serotonin content: physiological dependence on plasma tryptophan levels. Science 173:149-152.
11. Frackowiak RSJ, Friston KJ, Frith CD, Dolan RJ, Mazziotta JC, editors. 1997. Human brain function. San Diego: Academic Press.
12. 2-dopamine receptors in the monkey brain. Synapse 25:321-325.
13. 1A receptors. Synapse 35:192-200.
14. 1A receptors in rat brain membranes. Eur J Pharmacol 288:173-186.
15. Gunn RN, Lammertsma AA, Hume SP, Cunningham VJ. 1997. Parametric imaging of ligand-receptor binding in PET using a simplified reference region model. Neuroimage 6:279-287.
16. 11C]WAY-100635. Brain Res 745:96-108.
17. Hjorth S, Bengtsson HJ, Kullberg A, Carlzon D, Peilot H, Auerbach SB. 2000. Serotonin autoreceptor function and antidepressant drug action. J Psychopharmacol 14:177-185.
18. 1A receptors in rat brain, assessed using in vivo microdialysis and PET after fenfluramine. Synapse 41:150-159.
19. Kema IP, Meijer WG, Meiborg G, Ooms B, Willemse PH, de Vries EG. 2001. Profiling of tryptophan-related plasma indoles in patients with carcinoid tumors by automated, on-line, solid-phase extraction and HPLC with fluorescence detection. Clin Chem 47:1811-1820.
20. 1A receptor antagonist. Brain Res 673:217-225.
21. 1A receptor antagonist, to rat brain. J Neurochem 64:2716-2726.
22. 18F]altanserin. J Nucl Med 41:135P.
23. Laruelle M. 2000. Imaging synaptic neurotransmission with in vivo binding competition techniques: a critical review. J Cereb Blood Flow Metab 20:423-451.
24. 18F]MPPF, a fluoro analog of WAY-100635. Nucl Med Biol 25:343-350.
25. 11C]WAY-100635: effect of endogenous serotonin. Synapse 40:122-129.
26. McNair DM, Lorr M, Droppelman LF. 1971. Manual for the profile of mood states. San Diego: Educational and Industrial Testing Service.
27. Moja EA, Cipolla P, Castoldi D, Tofanetti O. 1989. Dose-response decrease in plasma tryptophan and in brain tryptophan and serotonin after tryptophan-free amino acid mixtures in rats. Life Sci 44:971-976.
28. 1A receptor in rat hippocampus. Brain Res 590:229-238.
29. Nénonéné EK, Radja F, Carli M, Grondin L, Reader TA. 1994. Heterogeneity of cortical and hippocampal 5-HT1A receptors: a reappraisal of homogenate binding with 8-[3H]hydroxydipropylaminotetralin. J Neurochem 62:1822-1834.
30. 1A receptor agonist 8-OH-DPAT. Eur J Pharmacol 358:147-152.
31. 18F]MPPF. J Nucl Med 41:1830-1835.
32. 18F]MPPF. Psychopharmacology 155:193-197.
33. 1A receptors with PET. Nucl Med Biol 27:467-471.
34. 11C]WAY-100635 sensitive to changes in brain 5-HT? Neuroimage 11:S9.
35. Riad M, Garcia S, Watkins KC, Jodoin N, Doucet E, Langlois X, el-Mestikawy S, Hamon M, Descarries L. 2000. Somatodendritic localization of 5-HT1A and preterminal axonal localization of 5-HT1B serotonin receptors in adult rat brain. J Comp Neurol 417:181-194.
36. 11C]WAY-100635: effects of depression and antidepressant treatment. Arch Gen Psychiatry 57:174-180.
37. Sharp T, Bramwell SR, Grahame-Smith DG. 1992. Effect of acute administration of L-tryptophan on the release of 5-HT in rat hippocampus in relation to serotoninergic neuronal activity: an in vivo microdialysis study. Life Sci 50:1215-1223.
38. 1A receptors in humans. Synapse 25:147-154.
39. Stancampiano R, Melis F, Sarais L, Cocco S, Cugusi C, Fadda F. 1997. Acute administration of a tryptophan-free amino acid mixture decreases 5-HT release in rat hippocampus in vivo. Am J Physiol 272:R991-994.
40. Talairach J, Tournoux P. 1989. Co-planar stereotaxic atlas of the human brain. Stuttgart: Georg Thieme Verlag.
41. 11C]raclopride in the human brain. Synapse 16:255-262.
42. 1A receptor agonist-antagonist binding affinity difference as a measure of intrinsic activity in recombinant and native tissue systems. Br J Pharmacol 130:1108-1114.
43. Westerink BHC, De Vries JB. 1991. Effect of precursor loading on the synthesis rate and release of dopamine and serotonin in the striatum: a microdialysis study in conscious rats. J Neurochem 56:228-233.
44. Williams WA, Shoaf SE, Hommer D, Rawlings R, Linnoila M. 1999. Effects of acute tryptophan depletion on plasma and cerebrospinal fluid tryptophan and 5-hydroxyindoleacetic acid in normal volunteers. J Neurochem 72:1641-1647.
45. Wurtman RJ, Fernstrom JD. 1975. Control of brain monoamine synthesis by diet and plasma amino acids. Am J Clin Nutr 28:638-647.
46. Young SN, Gauthier S. 1981. Effect of tryptophan administration on tryptophan, 5-hydroxyindoleacetic acid and indoleacetic acid in human lumbar and cisternal cerebrospinal fluid. J Neurol Neurosurg Psychiatry 44:323-327.
47. Young SN, Smith SE, Pihl RO, Ervin FR. 1985. Tryptophan depletion causes a rapid lowering of mood in normal males. Psychopharmacology 87:173-177.
48. 18F]MPPF, a potent in vivo tracer of the cerebral concentration of serotonin? Q J Nucl Med 45:S4.